Clinical application of regulatory T cells for treatment of type 1 diabetes and transplantation

This publication has 32 references indexed in Scilit:

• Induction of FOXP3 expression in naive human CD4+FOXP3− T cells by T-cell receptor stimulation is transforming growth factor-β–dependent but does not confer a regulatory phenotype
  Blood, 2007
• No Alterations in the Frequency of FOXP3+ Regulatory T-Cells in Type 1 Diabetes
  Diabetes, 2007
• Translational Mini-Review Series on Type 1 Diabetes: Systematic analysis of T cell epitopes in autoimmune diabetes
  Clinical and Experimental Immunology, 2007
• Interleukin‐10‐secreting type 1 regulatory T cells in rodents and humans
  Immunological Reviews, 2006
• FOXP3: Of Mice and Men
  Annual Review of Immunology, 2006
• Clinical application of expanded CD4+25+ cells
  Seminars in Immunology, 2006
• Regulatory T cells in human disease and their potential for therapeutic manipulation
  Immunology, 2006
• Innovative Immune-Based Therapeutic Approaches for the Treatment of Type 1 Diabetes Mellitus
  International Reviews of Immunology, 2005
• NaturallyArisingCD4⁺RegulatoryT Cells forImmunologicSelf-Tolerance andNegativeControl ofImmuneResponses
  Annual Review of Immunology, 2004
• Autoimmune Diseases as the Loss of Active “Self‐Control”
  Annals of the New York Academy of Sciences, 2003